Where does Takara Bio USA, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Takara Bio USA, Inc. ranks #6,287 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Takara Bio USA, Inc. hold?

Takara Bio USA, Inc. holds 54 US utility patents granted between 2016 and 2025, spanning 18 technology areas.

What is Takara Bio USA, Inc.'s Innovation Score?

Takara Bio USA, Inc. has an Innovation Score of 43.6 out of 100 (top 28% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Takara Bio USA, Inc.'s patent grant rate increasing or decreasing?

Takara Bio USA, Inc.'s recent grant velocity is +36% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Takara Bio USA, Inc.'s patents?

Takara Bio USA, Inc.'s patents average 20.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Takara Bio USA, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Takara Bio USA, Inc.

Q: What technology areas does Takara Bio USA, Inc. focus on?

Takara Bio USA, Inc.'s top technology area is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes) with 40 patents, ranking #112 of 2,502 assignees active in that subclass. Grants appear in 18 CPC subclasses total.

USPTO PatentsView assignee record - 54 granted patents across 18 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Takara ranks #6,287 of 49,997 tracked US assignees by granted-patent volume, with 54 patents across 18 technology areas.

#6,287
of 49,997 US assignees by volume: Top 28%
by Innovation Score (43.6/100): 20.3
avg claims per patent: +36%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6287 · US Corporation #6,287 · 54 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 54 grants
UPPER-Q #6,287/49,997
PHOTO-FINISH Technology Partners
CPC-FOCUS C12Q · 18 areas
INNOV-PAR 43.6/100
CLAIMS-DENSE 20.3 claims/avg
TYPE-USCORP US Corporation
VEL-UP +36% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Technology Partners LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Takara’s 43.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.8 pts (32%) Velocity 2.6 pts (6%) Breadth 15.0 pts (34%) Claim depth 12.2 pts (28%)

Qualcomm Incorporated · highest

85
Harmonic Drive Systems · near

44
HNI · near

44
NetScout Systems · near

44
Scholle IPN · near

44
Takara Bio USA · this assignee

44
3D Lighting… · lowest

7

What this shows Takara's Innovation Score is 43.6/100 (top 28% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Takara?

Each dot is one of Takara’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Takara’s own 20.3 claims/patent is ABOVE the 12.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Takara vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Takara's grants concentrate

Takara Bio USA, Inc. is a focused PatentsView assignee: 18 CPC subclasses with 74.1% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2021 (10 grants) versus a trough of 2 in 2016. By volume, Takara sits between Tiffany AND Company and The Secretary of State for Defence.

Takara's three-year grant acceleration

From 2019–2021 to 2022–2024, Takara Bio USA, Inc. moved from 28 to 11 grants (0.39x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Tiffany AND

54
TLV

54
Toho Titanium

54
Tripwire

54
Tecpharma Licensi…

54
Technology Partne…

54
Tekni-plex

54
The Secretary of…

54
Takara Bio USA ◀

54

What this shows Takara holds 54 patents at rank #6,290, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Takara

By rank, the assignees closest to #6,290 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Takara's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Takara, neither rank-band nor same-CPC leaders (those blocks stay above). In C12Q (Measuring OR Testing Processes Involving Enzymes), Takara ranks #112 of 2,502 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (44 here).

Scholle IPN Corporation 44 HNI Technologies Inc. 44 NetScout Systems, Inc. 44 Harmonic Drive Systems Inc. 44

Similar claim depth

Nearest assignees by average claims per patent (20.3 here).

Qwest Communications International Inc. 20.3 avg National Oilwell DHT, L.P. 20.3 avg Amyris, Inc. 20.3 avg NBCUniversal Media, LLC 20.3 avg

Takara's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 28% higher than 72% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Takara Bio USA, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	2	3.7%
2017	4	7.4%
2018	7	13.0%
2019	9	16.7%
2020	9	16.7%
2021	10	18.5%
2022	4	7.4%
2023	4	7.4%
2024	3	5.6%
2025partial year	2	3.7%

Which technologies does Takara Bio USA, Inc. patent most?

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 40

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 32

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 13

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 13

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 10

C12Y - Enzymes 10

C07K - Peptides 9

G06T - Image Data Processing OR Generation, IN General 3

B01D - Separation 3

H10F - Inorganic Semiconductor Devices Sensitive TO Infrared Radiation, Light, Electromagnetic Radiation OF Shorter Wavelength OR Corpuscular Radiation 2

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 2

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 2

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 2

F17D - Pipe-line SYSTEMS; Pipe-lines 1

Y10T - Technical Subjects Covered BY Former US Classification 1

Top 15 of 18 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Takara Bio USA, Inc.'s patent record in context - here's where to go next.

Takara Bio USA, Inc.'s lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 74.1% of its portfolio - see every assignee active in that class. Explore C12Q
Ranked #6,287 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Takara Bio USA, Inc. against Tiffany AND Company, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 43.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.